SEPN Septerna Pharma: Net earnings per share for the last 12 months

Public company logo of Septerna Corp (SEPN)

Septerna Inc (SEPN) is currently in an active investment phase and has not yet established a stable profit stream. The efficiency of its GPCR-based drug development is supported by a streamlined laboratory reagent supply system. The trailing twelve-month EPS dynamics on the precise GURU.Markets chart, where 14.20 captures the current state of the parameter, confirm the licensing potential and future high margins of free cash flow.

SEPN Septerna, Inc. Earnings per share for the last twelve months (11/23/2025 - 11/14/2026)

SEPN (Septerna Corp): analytical breakdowns and indicator data

- market value and analyst target forecast:
Stock Quotes septerna.com|SEPN - Price Target Chart
- company stock capitalization data:
Market Valuation Septerna, Inc.|SEPN - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Septerna|SEPN - Company Book Value|Capitalization to Book Value Ratio septerna.com|SEPN - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Septerna Inc|SEPN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Septerna Pharma|SEPN - Company Aggregate Debts|Debts to Book Value Septerna, Inc.|SEPN - Company Long-Term Debt|Current Liabilities Septerna|Intermediate Liquidity Ratio septerna.com
- earnings and multiples data:
SEPN - Net Profit|Expected Net Profit Septerna Inc|SEPN - Price to Earnings Ratio|Future Price to Earnings Multiple Septerna, Inc.|SEPN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Septerna, Inc.|SEPN - Operating profit EBITDA|Net earnings per share (EPS TTM) Septerna|SEPN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months septerna.com|SEPN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Septerna Inc
- revenue and sales details:
SEPN - Company Revenue|Company Revenue Forecast septerna.com|SEPN - P/S Multiple|Forward Price-to-Revenue Multiple Septerna, Inc.
Fundamental company valuation:SEPN, septerna.com
Core merchandise of Septerna Inc

A conservative analysis of Septerna Inc. (SEPN) requires the exclusion of short-term fiscal distortions to assess real business efficiency. The trailing twelve-month earnings per share trend, reflected in this 12-month YoY EPS growth chart, neutralizes one-time subsidies, confirming the resilience of the receptor-based drug development platform and the diversification of risks across the immunology and endocrinology segments for long-term capital growth.

Competitor analysis

argenx.com (ARGX) - Net earnings per share for the last 12 months|BioNTech (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax Corp|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) Protagonist Corp|Earnings per share for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (Grifols)|Adaptive Biotech (ADPT) - Net earnings per one share for the last twelve months|CLDX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aurinia Corp AUPH|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months veratx.com (VERA)|Earnings per share for the last twelve months Dianthus Therapeutics, Inc.|Pharvaris NV - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months ABCL (AbCellera Corp)|Earnings per share for the last four quarters TRML|Net earnings per share (EPS TTM) PGEN (Precigen, Inc.)|pharming.com (PHAR) - Net earnings per one share for the last twelve months|NKTR - Earnings per share for the last twelve months|Earnings per share for the trailing year UPB (Upstream Bio, Inc.)|Zenas Biopharma, Inc. (ZBIO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IMNM|GOSS (Gossamer Bio, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) kalvista.com|Net earnings per share for the last 12 months PVLA (Pieris Pharmaceuticals, Inc.)|SVRA (Savara Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|Net earnings per share for the last four quarters AnaptysBio Inc. (ANAB)|ATXS - Earnings per share for the last twelve months|ENGN (engene.com) - Earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aerovate Therapeutics|Earnings per share for the last twelve months Aclaris|Kyverna Therapeutics, Inc (KYTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) TLSA|CABA - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|THTX (Theratechnologies, Inc.) - Earnings per one share for the last 12 months|AVTX - Earnings per share for the last twelve months|ELDN (Eledon Pharmaceuticals, Inc) - Earnings per share for the last 12 months|Agenus (AGEN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months CLYM (climbbio.com)|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|ATYR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ikenaoncology.com (IMA)|Earnings per share for the last twelve months Shattuck Labs STTK|Earnings per share for the trailing year EQ|CNTB - Earnings per share for the last twelve months|Immunic, Inc. (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx (IFRX) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months XFOR|ACET: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CELU|Net earnings per share for the last four quarters INmune Bio Inc|Earnings per share for the last twelve months Barinthus Bio BRNS|KZR - Net earnings per share for the last 12 months|SABS - Earnings per share for the last twelve months|akaritx.com (AKTX) - Net earnings per share for the last 12 months|ENLV (enlivex.com) - Net earnings per share for the last 12 months|Q32 Bio (QTTB) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months GeoVax Labs Inc|Earnings per share for the last 12 months EDSA (Edesa Biotech Corp)|Net earnings per share (EPS TTM) IBIO|CARM - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months XTL Biopharmaceuticals Ltd. XTLB|Net earnings per share for the last four quarters Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aptevo Therapeutics|AIM ImmunoTech (AIM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ADTX (Aditxt, Inc.)|Net earnings per share for the last 12 months GRI|XRTX (XORTX Therapeutics Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) HIND|REVB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Indaptus Therapeutics INDP|Earnings per share for the trailing year SCNI|CALI - Earnings per share for the last twelve months|AFMD (Affimed) - Earnings per share for the last 12 months|ALLK: Net earnings per share (EPS TTM)|HOOKIPA Pharma (HOOK) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IGMS|ITOS: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OCEA|Net earnings per share for the last four quarters TC BioPharm (Holdings) Plc|Earnings per share for the last twelve months Third Harmonic Bio, Inc THRD